Aortic coarctation surgery
Jump to navigation
Jump to search
|
Aortic coarctation Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Aortic coarctation surgery On the Web |
|
American Roentgen Ray Society Images of Aortic coarctation surgery |
|
Risk calculators and risk factors for Aortic coarctation surgery |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Priyamvada Singh, M.B.B.S.[2], Cafer Zorkun, M.D., Ph.D. [3]; Assistant Editor(s)-In-Chief: Kristin Feeney, B.S.[4], Hibatullah Abdul Aleem, M.B.B.S[5]
Overview
The choice of intervention for coarctation of the aorta depends on the patient's age at presentation, the anatomy of the coarctation, hemodynamic severity, and the presence of associated cardiac defects. In symptomatic neonates with ductal-dependent coarctation, urgent surgical repair is the standard of care, preceded by intravenous prostaglandin E1 to maintain ductal patency until definitive repair can be performed. Open surgical repair is the treatment of choice in neonates, infants, and patients with long-segment coarctation, concomitant arch hypoplasia, or associated intracardiac defects. Resection with end-to-end anastomosis is the most widely used technique in older children and adults. Extended end-to-end anastomosis is preferred in neonates and infants with associated transverse arch hypoplasia, as it allows simultaneous arch augmentation. Patch aortoplasty has been largely abandoned due to high rates of late aneurysm formation at the repair site. Endovascular stent implantation is the preferred transcatheter approach for discrete native or recurrent coarctation in older children, adolescents, and adults with appropriate anatomy. Balloon-expandable covered stents are increasingly preferred over bare metal stents due to lower fracture rates and protection against aortic wall injury. Balloon angioplasty alone is reserved for situations where stent placement is not feasible and surgery is not an option, and carries a Class IIb recommendation per the 2018 AHA/ACC ACHD Guideline. Recoarctation occurs in approximately 10% of patients after surgical repair and 8% after balloon dilation, and requires lifelong surveillance with imaging every 3 to 5 years. Coarctation of the aorta is a lifelong vasculopathy rather than a condition cured by repair; 20 to 70% of patients develop late hypertension and mortality remains approximately 3-fold higher than the general population even after successful intervention.
Surgery
Indications for Intervention
Definition of Significant Coarctation
The 2022 ACC/AHA Aortic Disease Guideline and 2025 ACC/AHA ACHD Guideline provide standardized criteria for significant CoA requiring intervention.[1][2] Significant CoA is defined by the presence of upper extremity hypertension (at rest, on ambulatory BP monitoring, or with pathologic exercise BP response) or left ventricular hypertrophy, combined with at least one of the following criteria:
| Measurement Method | Threshold for Significance |
|---|---|
| Noninvasive BP difference (upper vs. lower extremity) | >20 mmHg |
| Peak-to-peak catheterization gradient | >20 mmHg; or >10 mmHg with decreased LV systolic function or significant collateral flow |
| Mean Doppler echocardiographic gradient | >20 mmHg; or >10 mmHg with decreased LV systolic function or significant collateral flow |
| Aortic isthmus ratio (smallest CoA diameter / descending aorta diameter at diaphragm) | <0.5 by expert consensus; <0.7 supported by more recent empirical data as an optimal threshold for recommending repair (2025 ACC/AHA ACHD Guideline Table 25)[2] |
Anatomic evidence of CoA by advanced imaging (CMR or CTA) should accompany hemodynamic criteria before proceeding with intervention.[1][3]
Guideline Recommendations for Intervention
| Guideline | Recommendation | COR | LOE |
|---|---|---|---|
| 2022 ACC/AHA Aortic Disease[1] | In patients with significant native or recurrent CoA and hypertension, endovascular stenting or open surgical repair is recommended | 1 | B-NR |
| 2018 AHA/ACC ACHD[3] | Surgical repair or catheter-based stenting is recommended for adults with hypertension and significant native or recurrent CoA | 1 | B-NR |
| 2018 AHA/ACC ACHD[3] | Balloon angioplasty for adults with native and recurrent CoA may be considered if stent placement is not feasible and surgical intervention is not an option | IIb | B-NR |
| 2025 ACC/AHA ACHD[2] | CoA repair should be performed by cardiovascular surgeons or interventionists with expertise in managing congenital heart disease | — | — |
Timing of Intervention
- Symptomatic neonates and infants: Urgent intervention after hemodynamic stabilization with prostaglandin E1. Definitive surgical repair is typically planned within 5–7 days of birth.[4]
- Asymptomatic infants and children: Elective repair is recommended before school age. Earlier repair is favored to prevent irreversible vascular remodeling and persistent hypertension; delayed repair beyond age 5 years is associated with higher rates of residual hypertension.[5]
- Adults with newly diagnosed CoA: Intervention is recommended when criteria for significant CoA are met. Untreated CoA carries a poor natural history. Campbell (1970) reported that approximately 75% of patients with untreated CoA died by age 46, with causes including heart failure, aortic rupture or dissection, bacterial endocarditis, and intracranial hemorrhage.[6]
Surgical Techniques
Open surgical repair remains the primary treatment modality for neonates, infants, and patients with complex anatomy. The choice of technique depends on patient age, anatomy, and associated anomalies.[1][7]
| Technique | Description | Key Considerations |
|---|---|---|
| Resection with end-to-end anastomosis (EEA) | Excision of the coarctation segment with direct reanastomosis of the aortic ends | Gold standard for discrete coarctation; first performed by Crafoord in 1944. Most widely used technique in older children and adults.[7] |
| Extended end-to-end anastomosis (EEEA) | Modified technique; extended resection with oblique anastomosis incorporating the undersurface of the aortic arch | Preferred in neonates and infants with associated transverse arch hypoplasia; allows simultaneous arch augmentation.[7] |
| Subclavian flap aortoplasty | Left subclavian artery divided distally and opened longitudinally to create a flap augmenting the narrowed segment | Uses autologous tissue with growth potential; historically common in infants. Sacrifices the left subclavian artery, with risk of left arm claudication or subclavian steal.[7] |
| Patch aortoplasty | Prosthetic or autologous patch placed to widen the stenotic segment without resection | Largely abandoned - associated with late aneurysm formation at the repair site in up to 38% of patients in some series. Not recommended as primary technique.[8] |
| Interposition graft / bypass graft | Tubular graft placed to bypass the coarctation segment; or extra-anatomic ascending-to-descending aortic bypass | Used for long-segment coarctation, redo surgery, or when direct anastomosis is not feasible. Ascending-to-descending bypass avoids redo thoracotomy.[1][7] |
- Surgical approach: Left posterolateral thoracotomy is the standard approach for isolated CoA repair. Median sternotomy is preferred when concomitant intracardiac repair is required (e.g., VSD closure, aortic arch reconstruction requiring cardiopulmonary bypass).[7]
- Neonatal mortality: Operative mortality for isolated CoA repair at experienced centers is generally low. Higher mortality is seen with associated complex cardiac anomalies, very low birth weight, and poor preoperative hemodynamic status.[9]
Transcatheter Stent Implantation
Endovascular stenting has become the preferred transcatheter approach for native and recurrent CoA in older children (generally >25 kg), adolescents, and adults with appropriate anatomy.[1][10]
- Balloon-expandable stents are preferred over self-expandable stents because their radial force overcomes elastic recoil at the coarctation site.[11]
- Covered stents (e.g., Covered Cheatham-Platinum Stent [CCPS]) reduce stent fracture risk and treat or prevent aortic wall injury. They are preferred when there is concern for vessel rupture or aortic wall abnormality.[12]
- Stents must be expandable to adult aortic size (minimum approximately 20 mm diameter), which limits use in small children.[4]
Balloon Angioplasty
- Native CoA in neonates: Balloon angioplasty is generally avoided in the first 6–12 months of life due to high rates of recoarctation and risk of aortic wall injury.[4]
- Recurrent CoA after surgical repair: Balloon angioplasty is the preferred initial approach for discrete recoarctation, as scar tissue at the repair site reduces the risk of aortic rupture compared with native CoA dilation.[4]
- Current guideline position: Balloon angioplasty for adults with native and recurrent CoA may be considered only if stent placement is not feasible and surgical intervention is not an option (2018 AHA/ACC ACHD: Class IIb, B-NR).[3]
Surgery vs. Stenting: Comparative Outcomes
Per the 2025 ACC/AHA ACHD Guideline:[2]
- Immediate hemodynamic results are similar between surgical repair and transcatheter stent therapy.
- Long-term data suggest a higher risk for reintervention (due to stent fracture, restenosis, and aneurysm/pseudoaneurysm) and less-complete LV reverse remodeling with transcatheter stent therapy compared with surgery.
- Therapy should be individualized according to thoracic aorta anatomy, procedural risk, and institutional expertise.
| Factors Favoring Surgery | Factors Favoring Endovascular Stenting |
|---|---|
| Long-segment coarctation | Discrete native or recurrent CoA with appropriate anatomy |
| Concomitant aortic arch hypoplasia | Adults with prior surgical repair developing recoarctation or aneurysm (avoids reoperation) |
| Associated intracardiac defects (VSD, large PDA) | Adequate iliofemoral access without supra-aortic trunk involvement |
| Neonates and small infants (<25 kg; stent not expandable to adult size) | Patient preference for less invasive approach |
| CoA with concomitant aneurysm requiring resection | — |
Management of Recoarctation
Recoarctation occurs in approximately 10% after surgical repair and 8% after balloon dilation; it is more common in patients repaired during infancy.[1][13]
- Discrete recoarctation: Percutaneous balloon angioplasty with or without stent placement is the preferred approach.[4]
- Long-segment recoarctation or concomitant arch hypoplasia: Surgical repair by surgeons with CHD expertise is recommended.[3]
- Recoarctation with aneurysm or pseudoaneurysm: Endovascular approach with covered stent is preferred when anatomically feasible.[1]
Procedural Complications
| Complication | Key Details |
|---|---|
| Paradoxical hypertension | Occurs in ~50% of patients post-repair; biphasic (sympathetic then RAAS-mediated). Management covered in Medical Therapy. |
| Aneurysm / pseudoaneurysm | Associated with all repair types; highest with prosthetic patch aortoplasty. After stenting, cumulative incidence ~6.3% at 5 years (COAST/COAST II).[14][8] |
| Aortic dissection / rupture | Risk is higher with balloon angioplasty of native CoA than with stenting or surgery.[4][3] |
| Spinal cord injury (paraplegia / paraparesis) | Historical CoA-specific series reported rates of approximately 0.1–1% in neonates and up to 2.6% in adults with poor collateral circulation; these figures derive from older CoA-specific literature rather than from the 2010 ACCF/AHA guideline, which addressed descending thoracic aortic repair broadly (2–6%) rather than CoA specifically. Contemporary data show this risk is now extremely low in CoA repair: the STS database (n=973 CoA repairs) reported zero spinal cord injuries, and a nationwide analysis of 11,907 CoA patients found neurological complication rates of only 0.05% for surgical and 0.2% for interventional repair in the modern era. Well-developed collateral networks in chronic CoA are protective. Risk increases with prolonged aortic cross-clamp time exceeding 30 minutes.[15][9] |
| Recoarctation | ~10% after surgery, ~8% after balloon dilation; higher in infants. Requires lifelong surveillance.[1] |
| Stent fracture | Cumulative incidence 24.4% at 5 years (COAST/COAST II); no clinically significant sequelae reported to date; covered stents reduce fracture risk.[14] |
| Vascular access injury | Femoral artery injury in ~3% of transcatheter procedures; higher with larger sheaths required for covered stents.[12][4] |
| Left arm complications | Subclavian steal, arm length discrepancy, or claudication may follow subclavian flap aortoplasty.[7] |
| Recurrent laryngeal nerve injury | Rare; associated with left thoracotomy approach. |
Long-Term Outcomes and Surveillance
Survival After Repair
- Long-term survival after CoA repair is significantly reduced compared with the general population.[5]
- CoA repair is not curative; it is the beginning of lifelong surveillance. Even after successful repair, 20–70% of patients develop late hypertension, and mortality remains approximately 3-fold higher than the general population.[16][5]
Post-Intervention Surveillance
Per the 2022 ACC/AHA Aortic Disease Guideline and the 2025 ACC/AHA ACHD Guideline:[1][2]
- Lifelong cardiology follow-up with evaluation by a cardiologist with ACHD expertise is recommended for all patients with CoA (repaired or not) (Class 1, C-EO).
- Aortic imaging (MRI or CT) is recommended for initial, surveillance, and follow-up evaluation (Class 1, B-NR). After establishing stable post-repair imaging, surveillance is typically obtained every 3–5 years.
- Blood pressure monitoring: Measure in both arms and one lower extremity at each visit. ABPM and exercise testing are recommended adjuncts. Target systolic BP <130 mmHg in adults.
- Screening for intracranial aneurysms by MRI or CT may be reasonable in adults with CoA (Class IIb, B-NR). The 2025 ACC/AHA ACHD Guideline notes that the role of routine screening remains unclear and most detected aneurysms are small and stable.[17][2]
Detailed pharmacologic management of post-repair hypertension is covered in Medical Therapy. Ongoing surveillance protocols are covered in Secondary Prevention.
Areas of Uncertainty
- Surgery vs. stenting: No large randomized trials directly compare long-term outcomes. The 2025 ACC/AHA ACHD Guideline notes that long-term data are limited and suggest higher reintervention rates with stenting, but therapy should be individualized.[2]
- Optimal stent type: Covered stents reduce fracture risk but do not eliminate late aneurysm formation. Bioresorbable and custom-made stents are under investigation but have not reached clinical use.
- Long-segment coarctation: Stent placement may be considered, but usefulness is not well established and long-term efficacy and safety are unknown.[10]
- Timing of repair in asymptomatic infants: No consensus on optimal age; earlier repair reduces hypertension risk but may increase recoarctation rates in very young infants.[4][13]
2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease[3]
Therapeutic Recommendations for Coarctation of the Aorta
| Class I |
| 1. Surgical repair or catheter-based stenting is recommended for adults with hypertension and significant native or recurrent coarctation of the aorta. (Level of Evidence: B-NR) |
| 2. Guideline-directed medical therapy (GDMT) is recommended for treatment of hypertension in patients with coarctation of the aorta. (Level of Evidence: C-EO) |
| Class IIb |
| 1. Balloon angioplasty for adults with native and recurrent coarctation of the aorta may be considered if stent placement is not feasible and surgical intervention is not an option. (Level of Evidence: B-NR) |
References
- ↑ 1.00 1.01 1.02 1.03 1.04 1.05 1.06 1.07 1.08 1.09 Isselbacher EM, Preventza O, Hamilton Black J III; et al. (2022). "2022 ACC/AHA guideline for the diagnosis and management of aortic disease". J Am Coll Cardiol. 80 (24): e223–e393. doi:10.1016/j.jacc.2022.08.004. PMID 36334952 Check
|pmid=value (help). - ↑ 2.0 2.1 2.2 2.3 2.4 2.5 2.6 Gurvitz M, Krieger EV, Fuller S; et al. (2025). "2025 ACC/AHA/HRS/ISACHD/SCAI guideline for the management of adults with congenital heart disease". J Am Coll Cardiol. doi:10.1016/j.jacc.2025.09.006. PMID 41411480 Check
|pmid=value (help). - ↑ 3.0 3.1 3.2 3.3 3.4 3.5 3.6 Stout KK, Daniels CJ, Aboulhosn JA; et al. (2019). "2018 AHA/ACC guideline for the management of adults with congenital heart disease". J Am Coll Cardiol. 73 (12): e81–e192. doi:10.1016/j.jacc.2018.08.1029. PMID 30121239.
- ↑ 4.0 4.1 4.2 4.3 4.4 4.5 4.6 4.7 Feltes TF, Bacha E, Beekman RH; et al. (2011). "Indications for cardiac catheterization and intervention in pediatric cardiac disease: a scientific statement from the American Heart Association". Circulation. 123 (22): 2607–52. doi:10.1161/CIR.0b013e31821b1f10. PMID 21536996.
- ↑ 5.0 5.1 5.2 Lee MGY, Babu-Narayan SV, Kempny A; et al. (2019). "Long-term mortality and cardiovascular burden for adult survivors of coarctation of the aorta". Heart. 105 (15): 1190–1196. doi:10.1136/heartjnl-2018-314257. PMID 30923175.
- ↑ Campbell M (1970). "Natural history of coarctation of the aorta". Br Heart J. 32 (5): 633–40. doi:10.1136/hrt.32.5.633. PMID 5470045.
- ↑ 7.0 7.1 7.2 7.3 7.4 7.5 7.6 Vasile CM, Laforest G, Bulescu C; et al. (2023). "From Crafoord's end-to-end anastomosis approach to percutaneous interventions: coarctation of the aorta management strategies and reinterventions". J Clin Med. 12 (23): 7350. doi:10.3390/jcm12237350. PMID 38068402 Check
|pmid=value (help). - ↑ 8.0 8.1 Forbes TJ, Kim DW, Du W; et al. (2011). "Comparison of surgical, stent, and balloon angioplasty treatment of native coarctation of the aorta: an observational study by the CCISC". J Am Coll Cardiol. 58 (25): 2664–74. doi:10.1016/j.jacc.2011.08.053. PMID 22152954.
- ↑ 9.0 9.1 Ungerleider RM, Pasquali SK, Welke KF; et al. (2013). "Contemporary patterns of surgery and outcomes for aortic coarctation: an analysis of the Society of Thoracic Surgeons Congenital Heart Surgery Database". J Thorac Cardiovasc Surg. 145 (1): 150–7. doi:10.1016/j.jtcvs.2012.09.053. PMID 23098750.
- ↑ 10.0 10.1 Goldstein BH, Kreutzer J (2021). "Transcatheter intervention for congenital defects involving the great vessels: JACC review topic of the week". J Am Coll Cardiol. 77 (1): 80–96. doi:10.1016/j.jacc.2020.11.019. PMID 33413945 Check
|pmid=value (help). - ↑ Czerny M, Grabenwöger M, Berger T; et al. (2024). "EACTS/STS guidelines for diagnosing and treating acute and chronic syndromes of the aortic organ". Eur J Cardiothorac Surg. 65 (2): ezad426. doi:10.1093/ejcts/ezad426. PMID 38408364 Check
|pmid=value (help). - ↑ 12.0 12.1 Taggart NW, Minahan M, Cabalka AK; et al. (2016). "Immediate outcomes of covered stent placement for treatment or prevention of aortic wall injury associated with coarctation of the aorta (COAST II)". JACC Cardiovasc Interv. 9 (5): 484–93. doi:10.1016/j.jcin.2015.11.038. PMID 26896890.
- ↑ 13.0 13.1 Dijkema EJ, Sieswerda GT, Takken T; et al. (2018). "Long-term results of balloon angioplasty for native coarctation of the aorta in childhood in comparison with surgery". Eur J Cardiothorac Surg. 53 (1): 262–268. doi:10.1093/ejcts/ezx239. PMID 28950330.
- ↑ 14.0 14.1 Holzer RJ, Gauvreau K, McEnaney K, Watanabe H, Ringel R (2021). "Long-term outcomes of the coarctation of the aorta stent trials". Circ Cardiovasc Interv. 14 (6): e010308. doi:10.1161/CIRCINTERVENTIONS.120.010308. PMID 34039015 Check
|pmid=value (help). - ↑ Trenk L, Lammers AE, Radke R; et al. (2021). "Neurological complications in aortic coarctation: results of a nationwide analysis based on 11,907 patients". Int J Cardiol. 322: 114–120. doi:10.1016/j.ijcard.2020.08.041. PMID 32798628 Check
|pmid=value (help). - ↑ Meijs TA, Minderhoud SCS, Muller SA; et al. (2021). "Cardiovascular morbidity and mortality in adult patients with repaired aortic coarctation". J Am Heart Assoc. 10 (22): e023199. doi:10.1161/JAHA.121.023199. PMID 34755532 Check
|pmid=value (help). - ↑ Buckley AD, Han Um KY, Ganame JI, Salehian O, Karbassi A (2023). "Prevalence of intracranial aneurysms in patients with coarctation of the aorta: a systematic review and meta-analysis". JACC Adv. 2 (5): 100394. doi:10.1016/j.jacadv.2023.100394. PMID 38938992 Check
|pmid=value (help).